In2Pharma
  • Home
  • Services
    • Regulatory Affairs
    • Quality Assurance
    • Publicity and Compliance
    • Medical writing & training
    • Vigilance
  • About Us
  • News
  • Contact
Select Page
New questions and answers from the EMA regarding Titanium Dioxide in Medicines

New questions and answers from the EMA regarding Titanium Dioxide in Medicines

by In2Pharma | Dec 2, 2022 | News

Europe A new questions and answers concerning titanium dioxide was published by the EMA. The Q&A, including five questions, gives guidance about the replacement or removal of titanium dioxide in medicines. Titanium dioxide (E 171) is commonly used in the...

Recent Posts

  • CBG starts authorizing temporarily different packaging
  • Update Guidance document describing the food categories in the Regulation on Food Additives
  • Mdeon, the Belgian ethical health platform, announces several novelties effective from January 1st, 2023.
  • Update on the pharmacovigilance system for Luxembourg
  • EMA recommends withdrawal of pholcodine medicines from EU market

Follow Us

  • Facebook
  • LinkedIn
Privacy Policy | Cookie Policy | BTW BE 895730662 | +32 16 89 16 00| info@in2pharma.com | Terloonststraat 22, 1910 Kampenhout, België